Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
State Street SPDR S&P Pharmaceuticals ETF
XPH
$549M
| $1.28M | ﹤0.01% |
30,052
+13,627
| +83% | +$578K |
|
4777
Alnylam Pharmaceuticals
ALNY
$31.7B
| $1.28M | ﹤0.01% |
10,876
-90,747
| -89% | -$7.75M |
|
4778
CALL
Alerian MLP ETF
AMLP
$13.4B
| $1.28M | ﹤0.01% |
22,780
+2,100
| +10% | +$120K |
|
4779
CALL
A.O. Smith
AOS
$8.21B
| $1.28M | ﹤0.01% |
21,500
-43,900
| -67% | -$2.46M |
|
4780
PUT
Amphenol
APH
$194B
| $1.28M | ﹤0.01% |
60,400
+28,800
| +91% | +$566K |
|
4781
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$584M
| $1.28M | ﹤0.01% |
20,728
+7,667
| +59% | +$456K |
|
4782
PUT
State Street SPDR S&P Insurance ETF
KIE
$709M
| $1.28M | ﹤0.01% |
42,600
+30,300
| +246% | +$903K |
|
4783
Sibanye-Stillwater
SBSW
$8.56B
| $1.28M | ﹤0.01% |
+303,828
| New | +$1.53M |
|
4784
CALL
Werner Enterprises
WERN
$2.3B
| $1.28M | ﹤0.01% |
34,900
-18,900
| -35% | -$600K |
|
4785
PUT
Curtiss-Wright
CW
$22B
| $1.27M | ﹤0.01% |
12,200
+6,100
| +100% | +$592K |
|
4786
CALL
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $1.27M | ﹤0.01% |
59,500
+17,500
| +42% | +$366K |
|
4787
Canadian Solar
CSIQ
$892M
| $1.27M | ﹤0.01% |
75,659
-122,941
| -62% | -$2.01M |
|
|
SVC
4788
PUT
Service Properties Trust
SVC
$1.02B
| $1.27M | ﹤0.01% |
8,940
-7,440
| -45% | -$1.05M |
|
4789
CALL
Peoples Bancorp
PEBO
$1.43B
| $1.27M | ﹤0.01% |
+37,900
| New | +$1.2M |
|
4790
PUT
Philips
PHG
$26.1B
| $1.27M | ﹤0.01% |
40,708
+27,666
| +212% | +$805K |
|
|
MULE
4791
CALL
DELISTED
MuleSoft, Inc.
MULE
| $1.27M | ﹤0.01% |
63,200
+42,700
| +208% | +$951K |
|
4792
PUT
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
| $1.27M | ﹤0.01% |
21,900
+5,800
| +36% | +$333K |
|
4793
PUT
Hecla Mining
HL
$13.7B
| $1.27M | ﹤0.01% |
253,300
+16,600
| +7% | +$85.2K |
|
4794
PUT
State Street SPDR S&P China ETF
GXC
$474M
| $1.27M | ﹤0.01% |
12,400
+7,900
| +176% | +$773K |
|
|
BREW
4795
CALL
DELISTED
Craft Brew Alliance, Inc.
BREW
| $1.27M | ﹤0.01% |
72,400
-5,300
| -7% | -$94K |
|
|
GNC
4796
DELISTED
GNC Holdings, Inc.
GNC
| $1.27M | ﹤0.01% |
143,813
-227,951
| -61% | -$2.05M |
|
4797
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.66B
| $1.27M | ﹤0.01% |
20,226
+7,500
| +59% | +$458K |
|
4798
PUT
Robert Half
RHI
$4.64B
| $1.27M | ﹤0.01% |
25,200
+19,900
| +375% | +$920K |
|
|
ESGW
4799
DELISTED
Columbia Sustainable Global Equity Income ETF
ESGW
| $1.27M | ﹤0.01% |
+42,249
| New | +$1.25M |
|
|
PGNX
4800
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.27M | ﹤0.01% |
172,000
+63,100
| +58% | +$401K |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.